Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Developing Countries: Health

International Development written question – answered on 10th September 2013.

Alert me about debates like this

Photo of Julian Huppert Julian Huppert Liberal Democrat, Cambridge

To ask the Secretary of State for International Development how much her Department has spent on research and development of new drugs, diagnostics and vaccines for global health through each of her Department's product development partnerships in each of the last five years; and how much she intends to spend in such fashion in each of the next five years.

Photo of Lynne Featherstone Lynne Featherstone The Parliamentary Under-Secretary of State for International Development

The following table shows details of the UK Government’s funding support to Product Development Partnerships (PDPs) in each of the last five financial years:

£
PDP 2008-09 2009-10 2010-11 2011-12 2012-13 Due beyond 2012-13
Aeras—TB Vaccines 4,000,000 5,500,000 1,000,000
Drugs for Neglected Diseases Initiative 2,000,000 5,000,000 5,381,529 6,000,000 6,508,021
Foundation for Innovative New Diagnostics 1,500,000 500,000 2,900,000 800,000 800,000
International AIDS Vaccine Initiative 6,000,000 10,000,000 8,000,000 7,500,000 8,500,000
International Partnership for Microbicides 2,500,000 7,500,000 3,500,000 2,000,000 4,500,000
Medicines for Malaria Venture 2,000,000 2,000,000 13,000,000 12,000,000 4,000,000 8,000,000
PATH—Diarrhoeal Diseases Vaccines 1,500,000 1,692,677 1,409,157 398,166
PATH—One World Health (Diarrhoeal Drugs) 2,000,000 2,950,000 750,000 750,000 750,000
PATH Meningitis Vaccine Programme 1,279,475 353,722 356,000 1,610,803
TB Alliance 3,000,000 5,686,384 7,313,616 6,300,000 1,000,000

The following table shows the overall level of funding recently awarded by the UK Government to each of the Product Development Partnerships for the period 2013-18—an annual breakdown of projected spend is not yet available.

Product Development Partnership Funding 2013-18 (£ million)
Aeras—TB Vaccines 10
Drugs for Neglected Diseases initiative 30
Foundation for Innovative New Diagnostics 10
Innovative Vector Control Consortium 12
International AIDS Vaccine Initiative 5
International Partnership for Microbicides 15
Medicines for Malaria Venture 25
PATH for new drugs and vaccines for diarrhoeal disease and diagnostics for malaria 16
TB Alliance 15
Total 138

Does this answer the above question?

Yes2 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.